Synthesis, antiproliferative, and vasorelaxing evaluations of coumarin α-methylene-γ-butyrolactones

被引:23
作者
Chen, YL [1 ]
Lu, CM
Lee, SJ
Kuo, DH
Chen, IL
Wang, TC
Tzeng, CC
机构
[1] Kaohsiung Med Univ, Coll Life Sci, Fac Med & Appl Chem, Kaohsiung 807, Taiwan
[2] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Taipei 114, Taiwan
[3] Tajen Inst Technol, Dept Pharm, Pingtong 907, Taiwan
关键词
coumarin; alpha-methylene-gamma-butyrolactones; vasorelaxing activity; antiproliferative activity;
D O I
10.1016/j.bmc.2005.06.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Certain coumarin alpha-methylene-gamma-butyrolactones were synthesized and evaluated for antiproliferative and vasorelaxing activities. These compounds were synthesized via alkylation of hydroxycoumarins 2a-f followed by oxidation and the Reformatsky-type condensation. The results of this study are as follows (1) for the vasorelaxing activity, coumarin-7-yl alpha-methylene-gamma-butyrolactone 6d, with an IC50 value of 9.4 mu M against pig coronary arterial contraction induced by KCl, is a more active vasorelaxant than its coumarin-4-yl counterpart 6a and its gamma-methyl congener 1. A methyl group substituted at C-4 of the coumarin-7-yl moiety reduced the vasorelaxing effect (6d vs 6e) while the 3,4,8-trimethyl derivative 6f was inactive. (2) For the antiproliferative activity, coumarin-4-yl alpha-methylene-gamma-butyrolactone 6a, which exhibited the most potent antiproliferative activity on the growth of MCF7, NCI-H460, and SF-268 with IC50 values of 6.97, 14.68, and 8.36 mu M, respectively, is more cytotoxic than its coumarin-7-yl counterpart 6d and the 6,7-dimethyl derivative 6b. For the coumarin-7-yl derivatives, 6d is more active than its gamma-methyl congener 1, indicating that substitution at the gamma-position decreased cytotoxicity. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5710 / 5716
页数:7
相关论文
共 34 条
[11]  
2-P
[12]   PSORALENES .3. CYCLIZATION STUDIES OF CERTAIN SUBSTITUTED COUMARINS AND COUMARANS [J].
ESSE, RC ;
CHRISTENSEN, BE .
JOURNAL OF ORGANIC CHEMISTRY, 1960, 25 (09) :1565-1569
[13]   Antimycobacterial evaluation of germacranolides [J].
Fischer, NH ;
Lu, TS ;
Cantrell, CL ;
Castañeda-Acosta, J ;
Quijano, L ;
Franzblau, SG .
PHYTOCHEMISTRY, 1998, 49 (02) :559-564
[14]   Tricyclic sesquiterpenes from Rudbeckia laciniata [J].
Fukushi, Y ;
Yajima, C ;
Mizutani, J ;
Tahara, S .
PHYTOCHEMISTRY, 1998, 49 (02) :593-600
[15]   SYNTHESIS AND BIOLOGICAL-ACTIVITY OF ALPHA-METHYLENE-GAMMA-BUTYROLACTONES [J].
HOFFMANN, HMR ;
RABE, J .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1985, 24 (02) :94-110
[16]   SYNTHESIS AND CONFIGURATIONAL ASSIGNMENT OF GEIPARVARIN - A NOVEL ANTI-TUMOR AGENT [J].
JERRIS, PJ ;
SMITH, AB .
JOURNAL OF ORGANIC CHEMISTRY, 1981, 46 (03) :577-585
[17]   REACTIONS OF ALPHA METHYLENE LACTONE TUMOR INHIBITORS WITH MODEL BIOLOGICAL NUCLEOPHILES [J].
KUPCHAN, SM ;
FESSLER, DC ;
EAKIN, MA ;
GIACOBBE, TJ .
SCIENCE, 1970, 168 (3929) :376-&
[18]   Synthesis and anticancer evaluation of certain α-methylene-γ-(4-substituted phenyl)-γ-butyrolactone bearing thymine, uracil, and 5-bromouracil [J].
Lee, KH ;
Huang, BR ;
Tzeng, CC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (02) :241-244
[19]   ANTITUMOR AGENTS .20. SESQUITERPENE ANTITUMOR AGENTS - INHIBITORS OF CELLULAR-METABOLISM [J].
LEE, KH ;
HALL, IH ;
MAR, EC ;
STARNES, CO ;
ELGEBALY, SA ;
WADDELL, TG ;
HADGRAFT, RI ;
RUFFNER, CG ;
WEIDNER, I .
SCIENCE, 1977, 196 (4289) :533-536
[20]   Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl) methoxy]quinolinone (CCT-62) [J].
Liao, CH ;
Tzeng, CC ;
Teng, CM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 349 (01) :107-114